Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-25 @ 7:38 PM
Study NCT ID:
NCT00697632
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2008-05-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Sponsor:
Mirati Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2018-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-14
First Submit QC Date:
None
Study First Post Date:
2008-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-11
Last Update Post Date:
2019-02-12
Last Update Post Date Type:
ACTUAL